Skip to main content
RNA logo

RNA · Atrium Therapeutics, Inc. · Held by Funds

Track RNA — free
$8.25 +0.20 (+2.48%)
Market Cap
$137.70M
Shares
17.11M
Volume · Oct 27 62.57K Avg daily vol (3M) 264.95K

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of RNA by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 11.21% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 2.67% 456,837
Index ETFs 8.54% 1,461,002
Active ETFs 0.76% 130,068
Active funds 9.41% 1,609,473
Unclassified 0.05% 8,533
All registered funds 21.43% 3,665,913
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding RNA

149 fund positions
Fund Balance Value % of Fund Open
Showing 1–50 of 149 positions
Key facts CIK 2093101 CUSIP 04965N104 13F (30d) 13 filings 13 filers Visit website Investor relations